Harvard Bioscience, Inc. – NASDAQ:HBIO
Harvard Bioscience stock price today
$0.49
-1.49
-75.25%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
Harvard Bioscience stock price monthly change
-39.26%
month
Harvard Bioscience stock price quarterly change
-39.26%
quarter
Harvard Bioscience stock price yearly change
-63.93%
year
Harvard Bioscience key metrics
Market Cap | 90.33M |
Enterprise value | 257.06M |
P/E | -21.96 |
EV/Sales | 2.26 |
EV/EBITDA | 106.44 |
Price/Sales | 1.87 |
Price/Book | 2.94 |
PEG ratio | N/A |
EPS | -0.20 |
Revenue | 106.78M |
EBITDA | 4.76M |
Income | -8.73M |
Revenue Q/Q | -18.22% |
Revenue Y/Y | -6.76% |
Profit margin | -8.4% |
Oper. margin | -6.32% |
Gross margin | 53.66% |
EBIT margin | -6.32% |
EBITDA margin | 4.46% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeHarvard Bioscience stock price history
Harvard Bioscience stock forecast
Harvard Bioscience financial statements
| Jun 2023 | 28.75M | -980K | -3.41% |
|---|---|---|---|
| Sep 2023 | 25.36M | -1.23M | -4.89% |
| Dec 2023 | 28.15M | -1.81M | -6.46% |
| Mar 2024 | 24.51M | -4.69M | -19.15% |
| Mar 2024 | 24.51M | -4.69M | -19.15% |
|---|---|---|---|
| Sep 2025 | 30.5M | 2.56M | 8.4% |
| Oct 2025 | 30.5M | 3.03M | 9.96% |
| Dec 2025 | 35M | 4.77M | 13.64% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 142899000 | 67.51M | 47.24% |
|---|---|---|---|
| Sep 2023 | 139735000 | 65.44M | 46.84% |
| Dec 2023 | 137366000 | 64.29M | 46.8% |
| Mar 2024 | 133161000 | 64.34M | 48.32% |
| Jun 2023 | 3.55M | -625K | -2.37M |
|---|---|---|---|
| Sep 2023 | 4.36M | -401K | -2.75M |
| Dec 2023 | 4.30M | -1.06M | -4.11M |
| Mar 2024 | 1.40M | -225K | -1.05M |
Harvard Bioscience alternative data
| Aug 2023 | 436 |
|---|---|
| Sep 2023 | 436 |
| Oct 2023 | 436 |
| Nov 2023 | 436 |
| Dec 2023 | 436 |
| Jan 2024 | 436 |
| Feb 2024 | 436 |
| Mar 2024 | 391 |
| Apr 2024 | 391 |
| May 2024 | 391 |
| Jun 2024 | 391 |
| Jul 2024 | 391 |
Harvard Bioscience other data
66.44%
-5.53%
of HBIO is owned by hedge funds
67
-19
28.27M
-1.38M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2023 | 25000 | 0 |
| Jun 2024 | 30000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | GREEN JAMES W director, officer.. | Common Stock | 10,000 | $2.91 | $29,100 | ||
Purchase | GREEN JAMES W director, officer.. | Common Stock | 20,000 | $3.07 | $61,400 | ||
Purchase | GREEN JAMES W director, officer.. | Common Stock | 25,000 | $4.38 | $109,500 | ||
Purchase | GREEN JAMES W director, officer.. | Common Stock | 20,000 | $2.6 | $52,000 | ||
Purchase | EDRICK ALAN I director | Common Stock | 16,192 | $2.62 | $42,423 | ||
Purchase | GREEN JAMES W director, officer.. | Common Stock | 20,000 | $2.67 | $53,400 | ||
Purchase | GREEN JAMES W director, officer.. | Common Stock | 15,000 | $2.61 | $39,150 | ||
Purchase | GREEN JAMES W director, officer.. | Common Stock | 15,000 | $2.41 | $36,150 | ||
Purchase | LOY BERTRAND director | Common Stock | 9,291 | $3.41 | $31,682 | ||
Purchase | LOY BERTRAND director | Common Stock | 8,244 | $3.34 | $27,535 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 7 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
Harvard Bioscience: Rally In Shares Losing Steam
Harvard Bioscience: Stock To Rise On Long-Term Growth And Attractive Valuation
Harvard Bioscience, Inc. 2022 Q4 - Results - Earnings Call Presentation
Bruker Corp.: My Top Ranked Holding In Laboratory Analytical Instruments
Harvard Bioscience: Undervalued, Underfollowed, And A Perfect Candidate For My 'Bio Boom' Portfolio
Week 33 MDA Breakout Stocks - August 2021: Short-Term Picks To Give You An Edge
-
What's the price of Harvard Bioscience stock today?
One share of Harvard Bioscience stock can currently be purchased for approximately $0.49.
-
When is Harvard Bioscience's next earnings date?
Unfortunately, Harvard Bioscience's (HBIO) next earnings date is currently unknown.
-
Does Harvard Bioscience pay dividends?
No, Harvard Bioscience does not pay dividends.
-
How much money does Harvard Bioscience make?
Harvard Bioscience has a market capitalization of 90.33M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.96% to 112.25M US dollars.
-
What is Harvard Bioscience's stock symbol?
Harvard Bioscience, Inc. is traded on the NASDAQ under the ticker symbol "HBIO".
-
What is Harvard Bioscience's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Harvard Bioscience?
Shares of Harvard Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Harvard Bioscience's key executives?
Harvard Bioscience's management team includes the following people:
- Mr. James W. Green Pres, Chief Executive Officer & Chairman(age: 67, pay: $822,970)
- Mr. Kenneth Fletcher Olson Chief Operating Officer(age: 63, pay: $526,220)
- Mr. Michael A. Rossi Chief Financial Officer(age: 51, pay: $423,080)
-
How many employees does Harvard Bioscience have?
As Jul 2024, Harvard Bioscience employs 391 workers.
-
When Harvard Bioscience went public?
Harvard Bioscience, Inc. is publicly traded company for more then 24 years since IPO on 19 Mar 2001.
-
What is Harvard Bioscience's official website?
The official website for Harvard Bioscience is harvardbioscience.com.
-
Where are Harvard Bioscience's headquarters?
Harvard Bioscience is headquartered at 84 October Hill Road, Holliston, MA.
-
How can i contact Harvard Bioscience?
Harvard Bioscience's mailing address is 84 October Hill Road, Holliston, MA and company can be reached via phone at +508 8938999.
Harvard Bioscience company profile:
Harvard Bioscience, Inc.
harvardbioscience.comExchange:
NASDAQ
Full time employees:
391
Industry:
Medical - Instruments & Supplies
Sector:
Healthcare
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
84 October Hill Road
Holliston, MA 01746
Holliston, MA 01746
CIK: 0001123494
ISIN: US4169061052
CUSIP: 416906105
